This study delineates a panel of transcriptionally and serologically validated biomarkers, RFC2, HSP90AB1, and YWHAZ (upregulated), and CYP2E1 and ADH4 (downregulated), that reflect core pathological processes in HCC. Here, RFC2 is linked to hepatocellular carcinoma.